Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Restore Medical
company
About
Restore Medical develops and provides a device-based therapy for congestive heart failure.
- 1 - 10
Highlights
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- €2M
- Industries
- Health Care,Health Diagnostics,Medical Device,Wellness
- Founded date
- Jan 1, 2016
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Restore Medical develops and provides a device-based therapy for congestive heart failure. It improves patient quality of life and reduce hospital readmission rates. Restore Medical's product, ContraBand, is a novel catheter-delivered implant in the pulmonary arteries for treatment of left ventricle failure, for patients with preserved right ventricle function.Restore Medical was founded in 2016 and is headquartered in Or Yehuda, Israel.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
€2M
Restore Medical has raised a total of
€2M
in funding over 2 rounds. Their latest funding was raised on
Jun 28, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 28, 2022 | Grant | €2M | 1 |
European Innovation Council
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Restore Medical is funded by 1 investors.
European Innovation Council
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
European Innovation Council
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
